Torrent Pharmaceuticals Ltd
Board Meeting Intimation for To Consider And Approve The Audited Financial Results On Standalone Basis And Unaudited Financial Results And Interim Dividend
03:52 PM, 13th Jan 2025
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on 31-Dec-24. The Board would also consider payment of Interim Dividend for the year 2024-25.
